-
To improve the quality of diagnosis and treatment, the country's first comprehensive diagnosis and treatment center for spinal tumors was established in Shanghai.
Time of Update: 2020-08-16
(Health Times reporter Yan Wei in Fudan University affiliated Zhongshan Hospital Juanan, Jin Xiaoxuan) to standardize the diagnosis and treatment of spinal tumors, improve patient satisfaction, training the spinal tumor comprehensive diagnosis and treatment of the talent team, recently, by Fudan University affiliated Zhongshan Hospital orthopaedics sponsored by the "10th all-spinal tumor whole-block removal study class and the 9th spinal surgery new technology forum", the country's first comprehensive spinal tumor diagnosis and treatment center was officially opened.
-
Howson Pharmaceuticals went to Hong Kong to list, spirit, anti-tumor drugs in the domestic leading.
Time of Update: 2020-08-16
and anti-tumor product line, Howson Pharmaceuticals is mainly in the treatment of high incidence of solid tumors and relatively limited treatment options of blood tumors, is China's fourth largest anti-tumor pharmaceutical company, the market share is currently 2.5%.
HS-10296 is the third-generation molecular targeting drug developed by Howson to treat lung cancer.
-
Chinese researchers find new lung cancer markers! Intervention inhibits tumor cell growth.
Time of Update: 2020-08-16
"Woman with the wind to buy weight loss pills 10 days after eating "liver injury" recently, Ms. Cao in Hangzhou listened to colleagues said that net red weight loss products "Enzyme Mei" effect is good, then also followed to buy to try.
-
The first new treatment in 15 years, the cancer treatment electric field has been approved for first-line treatment of mesothelioma.
Time of Update: 2020-08-16
Recently, Novocure announced that the U.S. FDA approved the company's NovoTTF-100L system to market, in conjunction with permeycere and platinum chemotherapy, first-line treatment can not be removed local late, or metastatic malignant thoracic mesothelioma (MPM).
NovoTTF-100L is a non-invasive, silky cancer therapy that uses an electric field to treat tumor areas.
-
The first osteocytoma therapy drug was approved, effectively inhibiting tumor growth.
Time of Update: 2020-08-16
Amgen China announced today that Angavi (generic name: diastoidal injection) has been approved by the State Drug Administration for the treatment of non-surgical lysis or surgical removal of bone cytomegaloomas that can cause severe dysfunction, including adults and adolescent patients with mature bones (at least 1 mature bone and weighing up to 45 kg).
-
With the help of clinical genetic testing of tumors, the use of Berry Gene Sequencer has expanded.
Time of Update: 2020-08-16
Clinically, tumor, genetic disease, reproductive health and other fields can also be used through genetic testing technology for clinically assisted diagnosis, disease monitoring, disease early screening and individualized drug use, biopharmaceutical research and development.
-
The second largest tumor in the blood system! New drugs for the treatment of multiple myeloma have been approved for sale.
Time of Update: 2020-08-16
On July 5, the State Drug Administration (FDA) conditionally approved the import registration application for Daratumumab Injection for single-drug treatment of adult patients with recurrent and refractory multiple myeloma, including patients who have previously received an protease inhibitor and an immunomodulator and developed the disease during the last treatment, according to the official website of the State Drug Administration.
-
The total survival rate increased by more than twice, and then Ding Pharma's first tumor electric field treatment products on the market.
Time of Update: 2020-08-16
"This innovative treatment for tumor electric field therapy has been shown to change the clinical treatment of glioblastoma, " said Liu Huilong, deputy director of oncology at the Seventh Medical Center of the PLA General Hospital.
-
Gynaecological malignant tumor patients aging, "red house technology" to protect life and son.
Time of Update: 2020-08-16
Professor Chen Xiaojun told reporters that the number of team outpatient clinics increased year by year, 2013-2018 membrane cancer and precancerous lesions care treatment 622 times, the effective mitigation rate of 95.7-97.4%, higher than the literature reported 70%-80%, in the hospital reproductive center assisted treatment patient pregnancy rate of 53.8%, also higher than the literature reported 30%-40%.
-
What new possibilities can artificial intelligence bring to cancer treatment? Listen to what the experts have to say.
Time of Update: 2020-08-16
"Artificial intelligence can provide doctors with more information in clinical diagnosis and treatment, more accurate judgment of the symptoms, efficacy, reduce the cycle of drug research and development, is the premise and basis for malignant tumors to achieve personalized precision treatment", recently, the Chinese Association of Cancer Association Cancer Artificial Intelligence Professional Committee was formally established, Tianjin Cancer Hospital Vice President Professor Xu Bo was elected as the first chairman of the Committee.
-
Thirty percent of cancer patients are malnourished! This diet is preferred for patients.
Time of Update: 2020-08-16
"Tumor cells provide the energy they need primarily through sugars, and the use of fat is poor, so a high-fat, low-carbohydrate diet should be the preferred option for tumor patients." Wang Kun, director of the nutrition department at Tianjin Cancer Hospital, said.
-
Treatment of nearly 2000 cases of cancer patients in 4 years! Shanghai Proton Heavy Ion Hospital Shines "Report Card"
Time of Update: 2020-08-16
On the 4th anniversary of the , patients participated in the this four-year-old clinical and scientific research "report card" shows that Shanghai Proton Heavy Ion Hospital relies on the advantages of heavy ion technology, around nasopharyngeal cancer, intracranial tumor, early lung cancer, liver cancer, prostate cancer and other five key diseases to carry out clinical treatment, and pancreatic cancer to carry out key clinical research ("5-1" key diseases), the current number of key treatment cases accounted for 63%.
-
Health and Health Commission sent a letter! Promote the introduction of medical insurance for drugs for children's hematology and malignant tumors.
Time of Update: 2020-08-16
for non-tumor children's blood diseases, establish and improve the network of diagnostic and treatment services, identify fixed-point hospitals, the implementation of provincial and municipal units of centralized treatment management.
-
China colorectal cancer tumor standardization diagnosis and treatment platform released.
Time of Update: 2020-08-16
Lin Lin, CEO of Anwant Smart Medical, said that the platform takes colorectal cancer as the starting point, mainly includes standardized diagnosis, standardized treatment, intelligent clinical assistance decision-making, tumor patients 360 degree view four parts, to provide clinical aids as the core value, through full-structured form, medical advice normative examination reminders, treatment plan recommendations, etc., to remind, intercept and avoid the occurrence of non-standardized diagnosis and treatment behavior.
-
Courier brother chest tumor can be like a ball! Shanghai experts teamed up to eliminate the tumor.
Time of Update: 2020-08-16
recently, Cao Ziang, chief of thoracic surgery at Renji Hospital affiliated with Shanghai Jiaotong University School of Medicine, teamed up with Lu Yi, deputy director of plastic surgery, to successfully perform a huge lump removal operation and rebuild the chest wall for the patient with right breast wall fibroid splinter.
-
The authoritative oncologist's heart said: cancer does not need to go abroad for treatment.
Time of Update: 2020-08-16
the Chinese Medical Association Cancer Branch-designate, Sun Yat-sen University Cancer Hospital Professor Lin Yu to proton radiotherapy to treat prostate cancer as an example, Shanghai has introduced equipment for early prostate cancer patients targeted and efficient treatment, a few years ago china is not this condition, but now up, the results proved to be very good, all over the country are also beginning to introduce new technology.
-
The 2019 China Hospital Impact Rankings were released.
Time of Update: 2020-08-16
Medical Trust World in particular independently released the Chinese hospital impact list of oncology professional list, the purpose is to remind the help and empower cancer diagnosis and treatment more accurate and more successful, break through the traditional medical technology in the cancer science bottleneck, to achieve early cancer prevention, early diagnosis, early treatment.
-
It's all 5G! Sun Yat-sen University Cancer Prevention and Control Center remote synchronization guidance 3 minimally invasive interventional surgery.
Time of Update: 2020-08-16
long-distance guidance, some members of the team of the Intervention Branch of Sun Yat-sen University Affiliated Oncology Hospital, under the leadership of Secretary Zhang Fujun and Director Jin Hua, came to Zhangzhou Cancer Hospital to visit 5G remote guidance surgical patients, conduct difficult case consultations and exchange information on medical and party building work.
-
5-year survival rate 71.26%! "Fudan Tumor" colorectal cancer prevention and treatment of the international leading.
Time of Update: 2020-08-16
Professor Cai Sanjun, chief expert of the multidisciplinary comprehensive treatment team for colorectal cancer at Fudan University's affiliated oncology hospital, introduced a phenomenon in which developed countries in Europe and the United States were once "big households" in the incidence of colorectal cancer.
-
Liang Ping: "Burn" tumor! China's original microwave ablation therapy in the forefront of the world.
Time of Update: 2020-08-16
Liang Ping, director of the Interventional Ultrasound Department of the PLA General Hospital and chairman-designate of the Ultrasound Medical Branch of the Chinese Medical Association, said that the biggest feature of microwave ablation therapy is small trauma and small impact on the patient's whole body, and this "original Chinese" surgical method has been among the most advanced in the world.
